Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -5.13% | 68.93 | 1.0% | $1428.71m | |
| BIIB | Biogen, Inc. | -0.44% | 308.71 | 1.5% | $631.84m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.95% | 435.69 | 2.6% | $529.95m | |
| AMGN | Amgen, Inc. | -2.49% | 198.43 | 1.3% | $513.30m | |
| ILMN | Illumina, Inc. | 0.10% | 260.19 | 3.5% | $396.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.90% | 221.30 | 1.9% | $345.30m | |
| MRNA | Moderna, Inc. | -11.32% | 23.20 | 0.0% | $335.20m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.67% | 92.71 | 2.0% | $222.19m | |
| CODX | Co-Diagnostics, Inc. | -14.16% | 13.70 | 0.0% | $212.35m | |
| A | Agilent Technologies, Inc. | -1.49% | 76.28 | 1.6% | $167.25m | |
| EXAS | EXACT Sciences Corp. | -0.21% | 80.65 | 24.0% | $163.27m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.07% | 89.76 | 4.3% | $114.66m | |
| SGEN | Seattle Genetics, Inc. | 3.24% | 111.82 | 6.1% | $109.33m | |
| INCY | Incyte Corp. | -1.69% | 74.56 | 2.5% | $108.52m | |
| NVAX | Novavax, Inc. | 30.51% | 15.40 | 184.0% | $85.79m |
Company Profile
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.